MiMedx Group Inc (MDXG)

NASDAQ
4.08
-0.12(-2.86%)
After Hours
4.08
0.00(0.00%)
- Real-time Data
  • Volume:
    417,423
  • Day's Range:
    4.03 - 4.20
  • 52 wk Range:
    3.04 - 15.98

MDXG Overview

Prev. Close
4.2
Day's Range
4.03-4.2
Revenue
256.26M
Open
4.2
52 wk Range
3.04-15.98
EPS
-0.25
Volume
417,423
Market Cap
462.4M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
474,554
P/E Ratio
-16.46
Beta
1.79
1-Year Change
-66.78%
Shares Outstanding
113,333,009
Next Earnings Date
Oct 27, 2022
What is your sentiment on MiMedx?
or
Market is currently closed. Voting is open during market hours.

MiMedx Group Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

MiMedx Group Inc Analysis

MiMedx Group Inc Company Profile

MiMedx Group Inc Company Profile

Employees
811

MiMedx Group, Inc. is a transformational placental biologics company, developing and distributing placental tissue allografts for multiple sectors of healthcare. The Company is focused on addressing unmet clinical needs in the areas of advanced wound care, surgical recovery applications, and musculoskeletal conditions. The Company’s primary platform technologies include EPIFIX, AMNIOFIX, EPICORD, and AMNIOCORD. The AMNIOFIX and EPIFIX are its tissue allografts derived from the amnion and chorion layers of the human placental membrane. Its EPICORD and AMNIOCORD are tissue allografts derived from umbilical cord tissue. EPIFIX is a semi-permeable, protective barrier allograft comprised of dehydrated human amnion/chorion membrane that may be used in the treatment of chronic wounds, including diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure ulcers. AMNIOFIX is used in surgical recovery applications including in the areas of spine, orthopedic, sports medicine and urologic.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuySell
Technical IndicatorsStrong BuySellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellStrong SellStrong BuyStrong Sell
  • https://www.presciencepoint.com/research/research-archives/mimedx/. . . READ
    1
    • gap up to zero. no financials, no cash, no future but lawsuits
      1
      • spoken like someone who has no clue
        0
    • $mdxg going to gap up. $15 must
      1
      • Lol you couldn’t possibly be more wrong
        0
    • The trend is super bullish.
      1
      • I am refinancing my house and will buy more soon. Not selling until $15.
        1
        • Im sorry for your loss
          0
      • $10 coming soon
        0
        • CEO and COO resign and investigation of accounting continues
          0
          • today it dropped to $4.20
            0
            • Short now
              0
              • mDXG is a big buy with 42% upside to a current price at $8.07
                1
                • Seems you were correct
                  1
                • For a while...
                  0